Trial Outcomes & Findings for Living With Multimorbidity: CO-ORDINATE Program (NCT NCT05985044)
NCT ID: NCT05985044
Last Updated: 2025-01-28
Results Overview
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
COMPLETED
NA
27 participants
Baseline, 6-weeks post intervention, 3 months post intervention
2025-01-28
Participant Flow
The participant was approached and recruited in the Intermediate Care Unit (IMCU) of an academic teaching hospital while the participants are in-patient before discharge. The recruitment of eligible participant took approximately 9 months from November 16, 2022 to August 2, 2023.
Out of the 27 participants who signed the informed consent, 25 completed the baseline survey and received the intervention. Two participants did not complete the baseline data collection and could not be reached after signing the consent form.
Participant milestones
| Measure |
Intervention
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Overall Study
STARTED
|
25
|
|
Overall Study
COMPLETED
|
10
|
|
Overall Study
NOT COMPLETED
|
15
|
Reasons for withdrawal
| Measure |
Intervention
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Overall Study
Death
|
6
|
|
Overall Study
Lost to Follow-up
|
4
|
|
Overall Study
Incapacitation
|
3
|
|
Overall Study
Withdrawal by Subject
|
2
|
Baseline Characteristics
Living With Multimorbidity: CO-ORDINATE Program
Baseline characteristics by cohort
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Age, Continuous
|
67 years
STANDARD_DEVIATION 7 • n=5 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
13 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
5 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
19 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
18 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
6 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
25 Participants
n=5 Participants
|
|
Symptom burden - Pain
|
4.34 units on a scale
STANDARD_DEVIATION 3.63 • n=5 Participants
|
|
Symptom burden - Tiredness
|
3.64 units on a scale
STANDARD_DEVIATION 2.89 • n=5 Participants
|
|
Symptom burden - Drowsiness
|
2.48 units on a scale
STANDARD_DEVIATION 2.76 • n=5 Participants
|
|
Symptom burden - Nausea
|
1.52 units on a scale
STANDARD_DEVIATION 2.87 • n=5 Participants
|
|
Symptom burden - Lack of appetite
|
1.02 units on a scale
STANDARD_DEVIATION 2.19 • n=5 Participants
|
|
Symptom burden - Shortness of breath
|
2.16 units on a scale
STANDARD_DEVIATION 2.76 • n=5 Participants
|
|
Symptom burden - Depression
|
1.78 units on a scale
STANDARD_DEVIATION 3.19 • n=5 Participants
|
|
Symptom burden - Anxiety
|
2.3 units on a scale
STANDARD_DEVIATION 2.97 • n=5 Participants
|
|
Symptom burden - Well-being
|
4.48 units on a scale
STANDARD_DEVIATION 3.27 • n=5 Participants
|
|
Quality of Life - Physical functioning
|
43.33 units on a scale
STANDARD_DEVIATION 30.31 • n=5 Participants
|
|
Quality of Life - Role Physical
|
27.08 units on a scale
STANDARD_DEVIATION 36.05 • n=5 Participants
|
|
Quality of Life -Role Emotional
|
48.61 units on a scale
STANDARD_DEVIATION 46.08 • n=5 Participants
|
|
Quality of Life - Vitality
|
42.08 units on a scale
STANDARD_DEVIATION 22.89 • n=5 Participants
|
|
Quality of Life - Mental Health
|
65 units on a scale
STANDARD_DEVIATION 26.49 • n=5 Participants
|
|
Quality of Life - Social Functioning
|
51.04 units on a scale
STANDARD_DEVIATION 35.72 • n=5 Participants
|
|
Quality of Life - General health
|
49.58 units on a scale
STANDARD_DEVIATION 22.07 • n=5 Participants
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Pain
Baseline
|
5 score on a scale
Interval 0.0 to 8.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Pain
6-week
|
4 score on a scale
Interval 1.0 to 6.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Pain
3-month
|
5 score on a scale
Interval 2.0 to 7.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Tiredness
Baseline
|
3 score on a scale
Interval 2.0 to 5.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Tiredness
6-week
|
3 score on a scale
Interval 3.0 to 4.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Tiredness
3-month
|
6 score on a scale
Interval 3.0 to 7.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Drowsiness
Baseline
|
2 score on a scale
Interval 0.0 to 5.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Drowsiness
6-week
|
3 score on a scale
Interval 0.0 to 4.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Drowsiness
3-month
|
5 score on a scale
Interval 2.0 to 6.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Nausea
Baseline
|
0 score on a scale
Interval 0.0 to 0.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Nausea
6-week
|
0 score on a scale
Interval 0.0 to 0.3
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Nausea
3-month
|
1 score on a scale
Interval 0.0 to 2.5
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Lack of Appetite
Baseline
|
0 score on a scale
Interval 0.0 to 0.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Lack of Appetite
6-week
|
1 score on a scale
Interval 0.0 to 6.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Lack of Appetite
3-month
|
3.3 score on a scale
Interval 1.0 to 4.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Shortness of Breath
Baseline
|
0 score on a scale
Interval 0.0 to 4.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Shortness of Breath
6-week
|
3 score on a scale
Interval 1.0 to 4.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Shortness of Breath
3-month
|
5 score on a scale
Interval 3.0 to 5.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Depression
Baseline
|
0 score on a scale
Interval 0.0 to 3.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Depression
6-week
|
3 score on a scale
Interval 1.0 to 5.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Depression
3-month
|
4.5 score on a scale
Interval 1.0 to 6.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Anxiety
Baseline
|
0 score on a scale
Interval 0.0 to 5.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Anxiety
6-week
|
2 score on a scale
Interval 0.5 to 6.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Anxiety
3-month
|
2.5 score on a scale
Interval 0.0 to 5.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
The ESAS questionnaire is used to rate the intensity of common symptoms including pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being, and shortness of breath; with ratings ranging from 0 (none, best) to 10 (worst).
Outcome measures
| Measure |
Intervention
n=25 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Well-being
Baseline
|
5 score on a scale
Interval 0.0 to 7.0
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Well-being
6-week
|
4 score on a scale
Interval 3.3 to 6.5
|
|
Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Well-being
3-month
|
3.3 score on a scale
Interval 2.0 to 5.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
Short Form Survey (SF-36) is a 36-item self-reported quality of life that covers 8 domains; score range 0 to 100. Higher score is better quality of life.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Physical Functioning
Baseline
|
50 score on a scale
Interval 12.5 to 62.5
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Physical Functioning
6-week
|
40 score on a scale
Interval 25.0 to 60.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Physical Functioning
3-month
|
32.5 score on a scale
Interval 10.0 to 65.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
Short Form Survey (SF-36) is a 36-item self-reported quality of life that covers 8 domains; score range 0 to 100. Higher score is better quality of life.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Role Physical
Baseline
|
25 score on a scale
Interval 0.0 to 25.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Role Physical
6-week
|
0 score on a scale
Interval 0.0 to 100.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Role Physical
3-month
|
0 score on a scale
Interval 0.0 to 75.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
Short Form Survey (SF-36) is a 36-item self-reported quality of life that covers 8 domains; score range 0 to 100. Higher score is better quality of life.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Role Emotional
Baseline
|
33.33 score on a scale
Interval 0.0 to 100.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Role Emotional
6-week
|
33.33 score on a scale
Interval 0.0 to 100.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Role Emotional
3-month
|
16.67 score on a scale
Interval 0.0 to 100.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
Short Form Survey (SF-36) is a 36-item self-reported quality of life that covers 8 domains; score range 0 to 100. Higher score is better quality of life.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Vitality
Baseline
|
45 score on a scale
Interval 22.5 to 60.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Vitality
6-week
|
50 score on a scale
Interval 35.0 to 50.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Vitality
3-month
|
52.5 score on a scale
Interval 50.0 to 65.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who competed the survey at each time point are reported.
Short Form Survey (SF-36) is a 36-item self-reported quality of life that covers 8 domains; score range 0 to 100. Higher score is better quality of life.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Mental Health
Baseline
|
68 score on a scale
Interval 48.0 to 88.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Mental Health
6-week
|
68 score on a scale
Interval 46.0 to 92.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Mental Health
3-month
|
76 score on a scale
Interval 44.0 to 88.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who completed the survey at each time point are reported.
Short Form Survey (SF-36) is a 36-item self-reported quality of life that covers 8 domains; score range 0 to 100. Higher score is better quality of life.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Social Functioning
Baseline
|
50 score on a scale
Interval 25.0 to 87.5
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Social Functioning
6-week
|
62.5 score on a scale
Interval 25.0 to 75.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Social Functioning
3-month
|
50 score on a scale
Interval 25.0 to 75.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who completed the survey at each time point are reported.
Short Form Survey (SF-36) is a 36-item self-reported quality of life that covers 8 domains; score range 0 to 100. Higher score is better quality of life.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Bodily Pain
Baseline
|
38.75 score on a scale
Interval 10.0 to 67.5
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Bodily Pain
6-week
|
57.5 score on a scale
Interval 42.5 to 67.5
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - Bodily Pain
3-month
|
50 score on a scale
Interval 45.0 to 60.0
|
PRIMARY outcome
Timeframe: Baseline, 6-weeks post intervention, 3 months post interventionPopulation: Participants who completed the survey at each time point are reported.
Short Form Survey (SF-36) is a 36-item self-reported quality of life that covers 8 domains; score range 0 to 100. Higher score is better quality of life.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - General Health
Baseline
|
50 score on a scale
Interval 30.0 to 65.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - General Health
6-week
|
45 score on a scale
Interval 25.0 to 80.0
|
|
Quality of Life Assessed by Short Form Survey (SF-36) Score - General Health
3-month
|
40 score on a scale
Interval 30.0 to 60.0
|
SECONDARY outcome
Timeframe: 3 months before and after entering the programPopulation: One outlier was excluded from the data.
Health-care utilization data will be retrieved from electronic medical records. The study team is defining healthcare utilization by identifying no. of total healthcare utilization, hospitalizations, emergency visits, and critical care admissions. Higher the numbers higher the healthcare utilization.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Health-care Utilization - Total Healthcare Utilization
3 months before entering the program
|
1 Care utilization events
Interval 1.0 to 2.0
|
|
Health-care Utilization - Total Healthcare Utilization
3 months after entering the program
|
1 Care utilization events
Interval 0.0 to 2.0
|
SECONDARY outcome
Timeframe: 3 months before and after entering the programPopulation: Participants who had data available are reported.
Health-care utilization data will be retrieved from electronic medical records. The study team is defining healthcare utilization by identifying no. of total healthcare utilization, hospitalizations, emergency visits, and critical care admissions. Higher the numbers higher the healthcare utilization.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Health-care Utilization - Emergency Department (ED) Visit s
3 months before entering the program
|
1 Care utilization events
Interval 1.0 to 2.0
|
|
Health-care Utilization - Emergency Department (ED) Visit s
3 months after entering the program
|
1 Care utilization events
Interval 0.0 to 1.5
|
SECONDARY outcome
Timeframe: 3 months before and after entering the programPopulation: Participants who had data available are reported.
Health-care utilization data will be retrieved from electronic medical records. The study team is defining healthcare utilization by identifying no. of total healthcare utilization, hospitalizations, emergency visits, and critical care admissions.. Higher the numbers higher the healthcare utilization.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Health-care Utilization - Hospitalization
3 months before entering the program
|
1 Care utilization events
Interval 1.0 to 1.0
|
|
Health-care Utilization - Hospitalization
3 months after entering the program
|
0 Care utilization events
Interval 0.0 to 1.0
|
SECONDARY outcome
Timeframe: 3 months before and after entering the programPopulation: Participants who had data available are reported.
Health-care utilization data will be retrieved from electronic medical records. The study team is defining healthcare utilization by identifying no. of total healthcare utilization, hospitalizations, emergency visits, and critical care admissions. Higher the numbers higher the healthcare utilization.
Outcome measures
| Measure |
Intervention
n=24 Participants
The participants received the Care cO-ORDInatioN And sympTom managEment (CO-ORDINATE) intervention, which includes the following four components: i) needs assessment, ii) question prompt list, iii) goals discussion, and iv) symptom assessment and tracking. The intervention comprises one in-person pre-discharge visit by the study team and four follow-up telephone calls conducted at 48 hours, 1 week, 4 weeks, and 6 weeks post-discharge.
|
|---|---|
|
Health-care Utilization - Critical Care Admission
3 months before entering the program
|
1 Care utilization events
Interval 1.0 to 1.0
|
|
Health-care Utilization - Critical Care Admission
3 months after entering the program
|
0 Care utilization events
Interval 0.0 to 0.5
|
Adverse Events
Intervention
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr.Binu Koirala
Johns Hopkins University School of Nursing
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place